| Ansøgningsnr. og dato | 18730161.9 (espacenet) (Federated) (European Patent Register), 20180501 | | Patent/reg.nr. og dato | DK/EP 3618842, 20231018 | | Tilgængelighedsdato | 20200311 | | Prioritetsnr. og dato | US 201762492947 P, 20170501, US 201762538670 P, 20170729, US 201762549390 P, 20170823, US 201762580433 P, 20171101, US 201762596753 P, 20171208 | | EP publ. nr. og dato |
EP 3618842 20200311 | | Løbedag | | | Ansøger/indehaver | Juno Therapeutics, Inc., 400 Dexter Avenue North, Suite 1200
Seattle, Washington 98109, US | | Ansøgers ref. nr. | P83249DK01 | | Opfinder | PORTS, Michael, c/o Juno Therapeutics Inc.
400 Dexter Ave. N
Suite 1200
Seattle, WA 98109, US,
WORKS, Melissa, c/o Juno Therapeutics Inc.
400 Dexter Ave. N
Suite 1200
Seattle, WA 98109, US,
BATUREVYCH, Oleksandr, 400 Dexter Ave. N
Suite 1200
Seattle, WA 98109, US,
SALMON, Ruth, 400 Dexter Ave. N
Suite 1200
Seattle, WA 98109, US,
HAUSE, Ronald, James, Jr., 400 Dexter Ave. N
Suite 1200
Seattle, WA 98109, US,
JOHNSTONE, Timothy, G., 400 Dexter Ave. N
Suite 1200
Seattle, WA 98109, US,
KUGLER, David, G., 400 Dexter Ave. N
Suite 1200
Seattle, WA 98109, US,
JONES, Jon, 400 Dexter Ave. N
Suite 1200
Seattle, WA 98109, US,
SONI, Neha, 400 Dexter Ave. N
Suite 1200
Seattle, WA 98109, US | | Fuldmægtig | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 31/454 (2006.01) , A61K 35/17 (2015.01) , A61P 35/00 (2006.01) | | Titel/benævnelse | KOMBINATION AF EN CELLETERAPI OG EN IMMUNOMODULERENDE FORBINDELSE | | Internationalt ansøgningsnr. | US2018030545 | | Internationalt publ. nr. | WO2018204427 | | Relateret sag (certifikat) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
